Literature DB >> 10491525

Occult metastases in the sentinel lymph nodes of patients with early stage breast carcinoma: A preliminary study.

K Dowlatshahi1, M Fan, K J Bloom, D J Spitz, S Patel, H C Snider.   

Abstract

BACKGROUND: Thirty percent of lymph node negative patients with operable breast carcinoma experience disease recurrence within 10 years. Retrospective serial sectioning of axillary lymph nodes has revealed undetected metastases in 9-30% of these patients. These occult metastases have been shown to have an adverse effect on survival. Serial sectioning (SS) is impractical for all axillary lymph nodes harvested from Levels I and II, but it is feasible if applied only to sentinel lymph nodes.
METHODS: Sentinel lymph nodes from 52 patients with invasive breast carcinoma were cut at 2 mm intervals, fixed in 10% formalin, and embedded in paraffin. Sections were taken from the blocks, stained with hematoxylin and eosin (H & E), and compared with cytokeratin-stained sections taken at 0.25 mm intervals throughout the entire blocks.
RESULTS: Tumor metastases were found in 6 patients (12%) when the sentinel lymph nodes were sectioned at 2 mm intervals and stained with H & E, compared with 30 patients (58%) when the same lymph nodes were serially sectioned at 0.25 mm intervals and stained with cytokeratin. Of 24 patients whose metastases were detected by SS and cytokeratin staining, 12 had isolated tumor cells and 12 had colonies of several thousand malignant cells.
CONCLUSIONS: Routine histologic examination of axillary lymph nodes, including sentinel lymph nodes, in cases of breast carcinoma significantly underestimates lymph node metastases. This deficiency may be overcome by SS of the entire lymph nodes and staining with a specific monoclonal antibody. The percentage of patients found to have colonies of cells that were missed by routine sectioning corresponds closely to the percentage of "lymph node negative" patients who would be expected to relapse. The true clinical significance of these occult metastases will be determined by long term follow-up. [See editorial on pages 905-7, this issue.] Copyright 1999 American Cancer Society.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10491525

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  16 in total

Review 1.  Axillary staging of breast cancer and the sentinel node.

Authors:  G Cserni
Journal:  J Clin Pathol       Date:  2000-10       Impact factor: 3.411

2.  Non-sentinel lymph node involvement in patients with breast cancer and sentinel node micrometastasis; too early to abandon axillary clearance.

Authors:  M A den Bakker; A van Weeszenberg; A Y de Kanter; F H Beverdam; C Pritchard; Th H van der Kwast; M Menke-Pluymers
Journal:  J Clin Pathol       Date:  2002-12       Impact factor: 3.411

3.  An evaluation of molecular markers for improved detection of breast cancer metastases in sentinel nodes.

Authors:  S Abdul-Rasool; S H Kidson; E Panieri; D Dent; K Pillay; G S Hanekom
Journal:  J Clin Pathol       Date:  2006-03       Impact factor: 3.411

4.  Clinical practice guidelines for the care and treatment of breast cancer: 13. Sentinel lymph node biopsy.

Authors:  J Cantin; H Scarth; M Levine; M Hugi
Journal:  CMAJ       Date:  2001-07-24       Impact factor: 8.262

5.  Sentinel node investigation in breast cancer: detailed analysis of the yield from step sectioning and immunohistochemistry.

Authors:  H Torrenga; F D Rahusen; S Meijer; P J Borgstein; P J van Diest
Journal:  J Clin Pathol       Date:  2001-07       Impact factor: 3.411

6.  Macrometastasis, micrometastasis, and isolated tumor cells in sentinel lymph nodes of early breast cancers: a 10-year histopathological and survival analysis of 537 Asian patients.

Authors:  Michael Co; Ava Kwong
Journal:  World J Surg       Date:  2015-06       Impact factor: 3.352

7.  Sentinel lymph node biopsy in early-stage breast cancer patients: improved survival through better staging?

Authors:  Pamela Meiers; Tulin Cil; Ulrich Guller; Markus Zuber
Journal:  Langenbecks Arch Surg       Date:  2012-12-11       Impact factor: 3.445

8.  Sentinel lymph node biopsy in breast cancer patients after overnight migration of radiolabelled sulphur colloid.

Authors:  N Lamichhane; K W Shen; C L Li; Q X Han; Y J Zhang; Z M Shao; Z Z Shen
Journal:  Postgrad Med J       Date:  2004-09       Impact factor: 2.401

Review 9.  Sentinel lymph node biopsy progress in surgical treatment of cancer.

Authors:  T Schulze; A Bembenek; P M Schlag
Journal:  Langenbecks Arch Surg       Date:  2004-06-09       Impact factor: 3.445

10.  Intraoperative Frozen Section Evaluation of Sentinel Lymph Nodes in Breast Carcinoma: Single-Institution Indian Experience.

Authors:  S P Somashekhar; Zahoor Ahmed Naikoo; Shabber S Zaveri; Soumya Holla; Suresh Chandra; Suniti Mishra; R V Parameswaran
Journal:  Indian J Surg       Date:  2013-02-05       Impact factor: 0.656

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.